Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2013-09-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Small studies with alexandrite lasers indicate that this may be an alternative treatment for individuals with nevus flammeus. This study assesses the clinical effect and side effects of alexandrite laser treatment for nevus flammeus using different treatment settings.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Naevus Flammeus Using Intense Pulsed Light and Pulsed Dye Laser
NCT00365118
A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology
NCT04999618
Fractional Laser as Treatment Option for Various Pigment Disorders
NCT01083498
Treatment of Axillary Hyperhidrosis With Long-pulsed Nd:YAG Laser or IPL
NCT04227691
Daylight-PDT With MAL for AK and Photodamaged Skin
NCT02736760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Alexandrite laser treatment
Alexandrite laser
3 different alexandrite laser settings are used in respectively 3 different treatment areas and compared with a non-treated control area.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alexandrite laser
3 different alexandrite laser settings are used in respectively 3 different treatment areas and compared with a non-treated control area.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fitzpatrick Skin Type I-III
* Previously untreated or pulsed dye laser-insufficiently treated nevus flammeus
* Nevus flammeus size minimum 8 x 2 centimeter within one anatomical region
* Written and oral informed consent
Exclusion Criteria
* Tendency to develop hypertrophic scars or keloids
* Fitzpatrick Skin Type IV-VI
* Individuals, that are obviously pigmented due to recent sun exposure or sun beds
* Treatment with systemic retinoids within 6 months
* Pregnancy and lactation
* Unwillingness to complete protocol
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merete Haedersdal
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Merete Haedersdal, Professor
Role: PRINCIPAL_INVESTIGATOR
Bispebjerg Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bispebjerg Hospital
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-4-2013-066
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.